Genus plc (GNS) Given Consensus Rating of “Buy” by Analysts
Genus plc (LON:GNS) has been given a consensus recommendation of “Buy” by the six research firms that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company.
A number of brokerages recently weighed in on GNS. Berenberg Bank began coverage on shares of Genus plc in a research report on Thursday, March 23rd. They set a “hold” rating on the stock. Liberum Capital restated a “buy” rating on shares of Genus plc in a research report on Tuesday, May 2nd. Peel Hunt restated a “buy” rating on shares of Genus plc in a research report on Thursday, June 1st. N+1 Singer restated a “hold” rating on shares of Genus plc in a research report on Monday, April 3rd. Finally, Numis Securities Ltd restated a “hold” rating on shares of Genus plc in a research report on Tuesday, April 4th.
Genus plc (GNS) traded down 2.15% during trading on Monday, hitting GBX 1727.00. 31,690 shares of the stock were exchanged. The stock’s market cap is GBX 1.05 billion. Genus plc has a 52 week low of GBX 1,650.00 and a 52 week high of GBX 2,113.00. The stock has a 50 day moving average of GBX 1,868.59 and a 200-day moving average of GBX 1,795.10.
Genus plc Company Profile
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.